PubMed HealthSearch

Biomedical subjects

J W Wilson

Publications and source records attributed to J W Wilson.

At least 19 recordsLinked to original sources

Paracetamol toxicity in hamster isolated hepatocytes: the increase in cytosolic calcium accompanies, rather than precedes, loss of viability.

Paracetamol is cytotoxic to hamster isolated hepatocytes by a mechanism that does not involve an early increase in [Ca2+]i. Although an increase in [Ca2+]i does occur, it accompanies rather than precedes, loss of viability. Studies with the ionophore, 4-bromo-A23187, suggest that although sustained elevations of [Ca2+]i per se can initiate cell death, this occurs at levels of [Ca2+]i only above 500 nM. This concentration was not achieved on exposure of cells to a cytotoxic concentration of paracetamol for 30 min. The [Ca2+]i-response of hepatocytes to vasopressin stimulation was not altered by exposing the cells to toxic concentrations of paracetamol. This demonstrates that paracetamol does not cause any impairment in the mobilisation or redistribution of Ca2+. The role of elevated levels of [Ca2+]i in mediating chemically-induced cell-killing requires re-evaluation.

Acetaminophen

Paracetamol toxicity and its prevention by cytoprotection with iloprost.

In a well-established two phase model of paracetamol toxicity in hamster hepatocytes cell death was accompanied, but not preceded, by a rise in cytosolic free calcium [Ca2+]i. Cell death appears to involve reversible oxidative damage, possibly to the cytoskeleton or mitochondria. In this model low concentrations (10(-8) to 10(-14) M) of iloprost, a stable analogue of prostacyclin, offered protection against the toxic effects of paracetamol. In preliminary studies with a rat liver epithelial cell line transduced with murine P4501A2 the toxicity of paracetamol was attenuated by iloprost. Inhibition of protein synthesis with cycloheximide had no effect on paracetamol toxicity but abolished the cytoprotective effect of iloprost.

Acetaminophen

Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer.

Although bacillus Calmette-Guerin (BCG) has been recognized as an effective therapy for superficial bladder cancer, dose-response studies are not available. Such studies are important because the administration of the vaccine is not devoid of significant side effects when the standard dose of 120 mg. is used. It has been speculated that smaller doses may be equally effective but carry fewer side effects. A controlled study comparing 2 doses of BCG was conducted as an initial step to explore this possibility. A total of 97 patients with a diagnosis of superficial (stages TIS, Ta and T1) bladder cancer was assigned to receive either 60 or 120 mg. BCG intravesically weekly for 6 weeks. The higher dose resulted in a better response for stages TIS, Ta (for prophylaxis of recurrence) and T1. However, the differences were not statistically significant. When stage TIS and Ta tumors coexisted, a significantly better response was recorded for the high dose. The overall success for the 2 treatments was 67% and 37% for the high and low doses, respectively. These differences reached statistical significance (p less than 0.02). Side effects were significantly less in number and severity in patients receiving the smaller dose of the vaccine.

BCG Vaccine

Effect of inhaled platelet-activating factor on bronchial inflammation in atopic non-asthmatic subjects.

We have investigated the effect of inhaled platelet-activating factor (PAF) on bronchial mucosal inflammation in 6 atopic non-asthmatic subjects in a double-blind, placebo-controlled, randomised and crossover study. On 2 study periods at least 4 weeks apart, fiberoptic bronchoscopy was performed 24 h after inhalation of either 200 micrograms PAF or methacholine (control) to obtain endobronchial biopsies. Immunocytochemistry using antibodies for trypase (AA1) and eosinophil cationic protein (EG2) was performed to enumerate mast cells and eosinophils, respectively, in the bronchial submucosa. Median values of AA1+ cells and EG2+ cells did not differ significantly after inhalation of PAF or control (23.8 vs. 39 and 6 vs. 8/mm2, respectively, PAF vs. control, non-significant). Our findings suggest that within 24 h of inhaling a bronchoconstrictor dose of PAF, this agonist does not induce bronchial hyperresponsiveness or mucosal inflammation in atopic non-asthmatic subjects. However, because of the small number of subjects studied, these preliminary data should be interpreted with caution.

Administration, Inhalation

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma.

The effect of inhaled corticosteroid therapy on airway mucosal inflammation was investigated in 10 symptomatic atopic asthmatic patients treated with inhaled albuterol and whose disease severity required preventative antiinflammatory treatment. Endobronchial biopsies were obtained by fiberoptic bronchoscopy before and after 6 wk of therapy with inhaled beclomethasone dipropionate (2,000 micrograms/day for 2 wk followed by 1,000 micrograms/day for 4 wk). Following treatment, there was a significant increase in mean morning peak expiratory flow (p less than 0.05) and baseline FEV1 measured on the day of methacholine challenge (p less than 0.05) and a decrease in asthma symptoms (p less than 0.01), peak expiratory flow variation (p less than 0.05), and albuterol usage (p less than 0.05). This was accompanied by a sevenfold decrease in airway responsiveness (p = 0.001). The clinical improvement in asthma was associated with a significant (p less than 0.05) reduction in epithelial and mucosal mast cells and eosinophils and submucosal T lymphocytes, but electron microscopy did not identify any changes in the extent of mast cell and eosinophil degranulation following treatment. Because of the association between the decrease in inflammatory cell numbers and the improvement in all the measured clinical and physiologic indices of asthma, we suggest that the beneficial effect of inhaled corticosteroids in asthma may be attributed to their antiinflammatory action in the bronchial mucosa.

Administration, Inhalation

Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma.

To study the role of T lymphocytes in atopic asthma we have examined cell populations in peripheral blood and bronchoalveolar lavage (BAL) from 12 atopic asthmatics and 10 healthy volunteers using flow cytometry and a panel of monoclonal antibodies directed toward T-cell surface antigens. BAL from asthmatics contained more eosinophils (mean, 0.54 +/- 11.2 x 10(6) versus 0.06 +/- 0.08 x 10(6) absolute count, p less than 0.05), but no greater total or percent of T lymphocytes. There was no difference between the two groups in the relative numbers of CD4+ or CD8+ T cells. However, there was a significant increase in the mean number of BAL CD3+ lymphocytes expressing the activation markers interleukin-2 receptor (IL-2R, CD25) (8.48 versus 4.37%, p less than 0.01) and human lymphocyte antigen-DR (11.08 versus 7.74%, p less than 0.05) in the asthmatics. In contrast to lavage cells, there was no difference in CD3+ cell activation markers in the peripheral blood. These findings suggest that T-lymphocyte activation occurs within the airways in symptomatic atopic asthma.

Adult

Risk analyses for the solar particle events of August through December 1989.

The solar particle events of August through December 1989, among the largest ever recorded, are analyzed to assess the potential hazards to humans on interplanetary missions from events of these types. Using the coupled neutron-proton space radiation transport computer code, BRYNTRN, risk estimates for the effects of exposures to the skin, ocular lens, and bone marrow are made for nominal thicknesses of the spacecraft aluminum shielding. Risk assessment in terms of absorbed dose is made for each event. Also presented are estimates of organ absorbed dose and dose equivalent for pairs of events which occurred within 30-day periods, and for the cumulative August through December 1989 period.

Elementary Particles

Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls.

We studied the role of atopy, as defined by positive skin tests to common inhalant allergens, in allergic bronchial inflammation. Endobronchial biopsies were taken via the fibreoptic bronchoscope in 13 symptomatic atopic asthmatics, 10 atopic nonasthmatics, and 7 normals. The numbers of mast cells, identified in the submucosa by immunohistochemistry using the AA1 monoclonal antibody against tryptase, were no different between the three groups, but electron microscopy showed that mast cell degranulation, although less marked in atopic nonasthmatics, was a feature of atopy in general. The numbers of eosinophils, identified by immunohistochemical staining using the monoclonal anti-eosinophil cationic protein antibody, EG2, were greatest in the asthmatics, low or absent in the normals and intermediate in the atopic nonasthmatics. In both atopic groups eosinophils showed ultrastructural features of degranulation. Measurements of subepithelial basement membrane thickness on electron micrographs showed that the collagen layer was thickest in the asthmatics, intermediate in the atopic nonasthmatics and thinnest in the normals. The results suggest that airways eosinophilia and degranulation of eosinophils and mast cells, as well as increased subepithelial collagen deposition, are a feature of atopy in general and suggest that the degree of change may determine the clinical expression of this immune disorder.

Adult

Interplanetary crew exposure estimates for galactic cosmic rays.

Using the Langley Research Center galactic cosmic-ray transport computer code and the Computerized Anatomical Man model, initial estimates of interplanetary exposure of astronauts to galactic cosmic rays, during periods of solar minimum activity, are made for a realistic human geometry shielded by various thickness of spacecraft aluminum shielding. Conventional dose assessment in terms of total absorbed dose and dose equivalent is made for the skin, ocular lens, and bone marrow. Included in the analyses are separate evaluations of the contributions from the incident primary ions, from subsequent-generation fragmentation products, and from target fragments. In all cases considered, the equivalent sphere approximation yielded conservative overestimates for the actual organ exposures.

Cosmic Radiation

Pyrophosphate inhibition of Proteus mirabilis-induced struvite crystallization in vitro.

Struvite (MgNH4PO4.6H2O) crystals, the major mineral component of infectious urinary calculi, were produced in vitro by growth of a clinical isolate of Proteus mirabilis in artificial urine. P. mirabilis growth and urease-induced struvite production were monitored by phase contrast light microscopy and measurements of urease activity, pH, ammonia concentrations, turbidity, and culture viability. In the absence of pyrophosphate, struvite crystals appeared within 3-5 h due to the urease-induced elevation of pH and initially assumed a planar or 'X-shaped' crystal habit (morphology) characteristic of rapid growth. When pyrophosphate was present, initial precipitation and crystal appearance were significantly impaired and precipitates were largely amorphous. When crystals did appear (usually after 7 or 8 h) they were misshapen or octahedral in shape indicative of very slow growth. X-ray diffraction and Fourier transform infrared spectroscopy (FTIR) identified all crystals as struvite. Trace contaminates of carbonate-apatite (Ca10(PO4)6CO3) or newberyite (MgHPO4.H2O) were produced only in the absence of pyrophosphate. P. mirabilis viability and culture pH elevation were unaffected by the addition of pyrophosphate, whereas urease activity and ammonia concentrations were marginally reduced. Struvite could also be produced chemically by titration of the artificial urine with NH4OH. If pyrophosphate was present during titration, the same inhibitory effect on crystal growth occurred, so it is unlikely that urease inhibition is important. Lowering of pyrophosphate concentration from 13-0.45 mumol/l did not reduce its inhibitory activity so it is unlikely to act by chelating free Mg2+. We propose that pyrophosphate inhibits struvite growth principally through direct interference with the chemical mechanisms involved in crystal nucleation and growth, because of its effectiveness at very low concentrations.

Ammonia

Effect of circumferential bands on cortical vascularity and viability.

Wire cerclage devices do not restrict cortical vascularity; however, bands, because they are flat and wide, have been implicated as the cause of fracture nonunion by disruption of cortical vascularity. This experiment evaluated the effect of cerclage bands on the cortical vascularity of bones that had not been fractured. Stainless-steel bands of four sizes (2.5, 5.0, 7.5, and 10.0 mm wide) and nylon bands of five sizes (2.5, 3.6, 4.8, 7.6, and 9.0 mm wide) were applied 1 cm apart to both femoral diaphyses of four mature dogs. In two additional dogs, 18-gauge cerclage wires were applied 5 mm apart on one femur and nylon bands were applied immediately adjacent to one another on the other femur to cover 3 cm of the length of each femoral diaphysis. These six dogs were euthanatized and perfused 7 days postoperatively and specimens were studied by microangiography and correlated histology. Two additional dogs were studied 4 and 15 weeks after application of nylon and metal bands. There was no evidence of complete cortical devascularization under any size or type of cerclage appliance at any time interval. Numerous examples of vessels traversing the cortex directly beneath all the cerclage appliances were observed. Cerclage devices, even when flat and wide, do not restrict cortical vascularity when applied to intact bones.

Angiography

Analytical relationships of nuclear field and microdosimetric quantities for target fragmentation in tissue systems.

A simple analytic formula for the nuclear fields formed by target fragmentation in tissue systems is derived using the continuous slowing down approximation (CSDA). The energy fluctuations in sensitive localized sites within the tissue system caused by these nuclear events are defined by microdosimetry. In that CSDA is used, the energy fluctuations exclude the role of secondary electrons. The relations also relate to the response of microdosimetric devices to nuclear fragmentation fields.

Ions

Nuclear reaction effects in use of newly recommended quality factor.

The biological risk for energetic ion exposure cannot be reliably estimated exclusive of the target nuclear reaction products produced within the local tissue. A theoretical basis is derived for evaluating target fragment contributions that are evaluated for the newly proposed quality factor.

Humans

Mucosal nerves in endobronchial biopsies in asthma and non-asthma.

To investigate neural events within the airways in asthma, endobronchial biopsies were obtained by fibre-optic bronchoscopy from 8 atopic asthmatic subjects and 8 non-atopic healthy controls. The biopsies were immediately fixed on sampling and subsequently analysed for nerves using specific indirect immunofluorescence with antisera to the neural marker PGP 9.5 and to the neuropeptides vasoactive intestinal peptide (VIP), substance P (SP) and calcitonin gene-related peptide (CGRP). Nerves were present in all the biopsies from both subject groups, with no significant difference between the asthmatic and non-asthmatics. VIP-immunoreactive nerves were equally present in both subject groups, being localized to smooth muscle and glandular sites. No immunoreactive nerves to SP or CGRP could be identified in any biopsy at any location. These in vivo findings do not identify an anatomical neuronal imbalance in asthma.

Adult

The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma.

We have documented the physiologic effects of fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) and endobronchial biopsy performed under local anesthesia in 20 asthmatic subjects, 8 healthy nonatopic control subjects, and 8 atopic nonasthmatic subjects. Premedication consisted of nebulized albuterol (2.5 mg; except for the study of atopic nonasthmatic subjects), ipratropium bromide (500 micrograms), and intramuscular atropine (0.6 mg). Intravenous midazolam was given for mild sedation, and oxygen was delivered via a nasal cannula. FEV1 was measured before and after premedication, immediately postbronchoscopy, and after 2 h recovery. There was a significant fall in mean (+/- SD) FEV1 immediately postbronchoscopy in both the asthmatic (26.2 +/- 16.7%; p less than 0.001) and normal (9 +/- 4.7%, p less than 0.05) groups, which in the asthmatic subjects correlated inversely with the concentration of methacholine provoking a 20% fall in FEV1 (PC20) measured 5 days prebronchoscopy (r = -0.74, p less than 0.001) but not with symptom scores, albuterol use, or peak expiratory flow (PEF) variation recorded during 2 wk before the investigation. There was significant arterial hemoglobin O2 desaturation during biopsy in the asthmatic subjects (median 3%, range -1 to 17% fall from baseline; p less than 0.01), which was not related to any of the measured indices of asthma severity. PC20, measured 5 days before and 5 days after bronchoscopy in the asthmatic subjects and 2 days before and 1 day after bronchoscopy in the atopic nonasthmatic subjects was not significantly affected by the procedure. We conclude that fiberoptic bronchoscopy with BAL and endobronchial biopsy can be conducted safely in asthmatic subjects, but requires caution in those with very responsive airways.(ABSTRACT TRUNCATED AT 250 WORDS)

Adult

Biological effectiveness of high-energy protons: target fragmentation.

High-energy protons traversing tissue produce local sources of high-linear-energy-transfer (LET) ions through nuclear fragmentation. We examine the contribution of these target fragments to the biological effectiveness of high-energy protons using the cellular track model. The effects of secondary ions are treated in terms of the production collision density using energy-dependent parameters from a high-energy fragmentation model. Calculations for mammalian cell cultures show that at high dose, at which intertrack effects become important, protons deliver damage similar to that produced by gamma rays, and with fragmentation the relative biological effectiveness (RBE) of protons increases moderately from unity. At low dose, where sublethal damage is unimportant, the contribution from target fragments dominates, causing the proton effectiveness to be very different from that of gamma rays with a strongly fluence-dependent RBE. At high energies, the nuclear fragmentation cross sections become independent of energy. This leads to a plateau in the proton single-particle-action cross section, below 1 keV/micron, since the target fragments dominate.

Cell Survival

Interplanetary crew exposure estimates for the August 1972 and October 1989 solar particle events.

Using the coupled neutron-proton space radiation transport computer code (BRYNTRN), estimates of human exposure in interplanetary space, behind various thicknesses of aluminum shielding, are made for the large solar proton events of August 1972 and October 1989. A comparison of risk assessment in terms of total absorbed dose for each event is made for the skin, ocular lens, and bone marrow. Overall, the doses associated with the August 1972 event were higher than those with the October 1989 event and appear to be more limiting when compared with current guidelines for dose limits for missions in low Earth orbit and more hazardous with regard to potential acute effects on these organs. Both events could be life-threatening if adequate shielding is not provided.

Bone Marrow